New Oesophageal Cancer Diagnostic shows strong performance
Filed with ASX · · 12 pages · English
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- OxiDx launched to maximise oxidative stress technology
- Completion of Placement and Exercise of Performance Rights
- Proteomics raises $8m in highly successful Placement
- Proteomics signs binding LOI with Sonic Healthcare USA
- Clinical Utility Study demonstrates PromarkerD test benefits
Later from Proteomics International Laboratories
- Proteomics receives $1.7 million in R&D tax incentive
- Precision diagnostics facility receives $2m funding boost
- September 2022 Quarterly Activities Report and Appendix 4C
- PromarkerD patent granted in Hong Kong
- AGM Chairmans Address and Investor Presentation
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories